Table 5.
Various agents to control bacterial wilt diseases caused by R. solanacearum in the present report.
| Compounds or Natural Extracts | Bacterial Strain | Inhibition Effect | References | ||
|---|---|---|---|---|---|
| EC50 (µg/mL) a | MIC (µg/mL) b | DIZ (mm) c | |||
| 2-Mercapto-5-substituted-1,3,4-oxadiazole/thiadiazole derivatives | R. solanacearum | 15.14–109.61 | -- d | -- | [44] |
| Imine derivatives of quinazoline-4(3H)-one | R. solanacearum | 38.64–201.52 | -- | -- | [45] |
| Coumarin | R. solanacearum | 198.64 | 384 | -- | [46] |
| Leaf essential oil isolated from Macleaya cordata R. Br | R. solanacearum | -- | 125 | 18.6 ± 1.9 | [47] |
| Yanglingmycin and its analogues | R. solanacearum | -- | 3.91–125 | -- | [48] |
| Polyphenols isolated from Spiromastix sp. MCCC 3A00308 | R. solanacearum | -- | 0.5–128 | -- | [49] |
| CTS-g-CA | R. solanacearum including GMI1000, GIM1.76, GIM1.74, GIM1.71 and RS-5 | 42.1–800.0 | -- | -- | [32] |
| CAPE | R. solanacearum including GMI1000, GIM1.76, GIM1.74, GIM1.71 and RS-5 | 165.2–752.7 | -- | -- | This work |
a EC50, half maximal effective concentration; b DIZ, diameter of inhibition zone; c MIC, minimum inhibitory concentration; d not elsewhere specified.